Weiss Asset Management’s Immunic IMUX Stock Holding History

Weiss Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28	Closed	-$76K	–	212
2018 Q2	$76K	Buy	+28	New	+$64.7K	0.01%	172

Other funds holding IMUX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Weiss Asset Management's IMUX Position: Q3 2018 in Review

Weiss Asset Management sold out of Immunic (IMUX) in Q3 2018, closing a stake of 28 shares — an estimated $76K sold.

Weiss Asset Management first reported a position in IMUX in Q2 2018 and held it in 1 quarter. The position peaked at $76K in Q2 2018. 54 funds tracked by Wall St. Rank hold IMUX as of Q3 2018.

Weiss Asset Management reported no remaining Immunic position as of Q3 2018 after selling out during the quarter.
Weiss Asset Management sold 28 Immunic shares in Q3 2018, an estimated $76K.
Weiss Asset Management first reported a position in Immunic in Q2 2018 and held it in 1 quarter.
Weiss Asset Management's Immunic position peaked at $76K in Q2 2018.
54 funds tracked by Wall St. Rank held Immunic as of Q3 2018.

Based on Weiss Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.